Charles Explorer logo
🇨🇿

Quantitative In Vivo Monitoring of Hypoxia and Vascularization of Patient-Derived Murine Xenografts of Mantle Cell Lymphoma Using Photoacoustic and Ultrasound Imaging

Publikace na Lékařská fakulta v Plzni, 1. lékařská fakulta |
2021

Tento text není v aktuálním jazyce dostupný. Zobrazuje se verze "en".Abstrakt

Tumor oxygenation and vascularization are important parameters that determine the aggressiveness of the tumor and its resistance to cancer therapies. We introduce dual-modality ultrasound and photoacoustic imaging (US-PAI) for the direct, non-invasive real-time in vivo evaluation of oxygenation and vascularization of patient-derived xenografts (PDXs) of B-cell mantle cell lymphomas.

The different optical properties of oxyhemoglobin and deoxyhemoglobin make it possible to determine oxygen saturation (sO(2)) in tissues using PAI. Highfrequency color Doppler imaging enables the visualization of blood flow with high resolution.

Tumor oxygenation and vascularization were studied in vivo during the growth of three different subcutaneously implanted patientderived xenograft (PDX) lymphomas (VFN-M1, VFN-M2 and VFN-M5 R1). Similar values of sO(2) (sO(2) Vital), determined from US-PAI volumetric analysis, were obtained in small and large VFN-M1 tumors ranging from 37.9 +/- 2.2 to 40.5 +/- 6.0 sO(2) Vital (%) and 37.5 +/- 4.0 to 35.7 +/- 4.6 sO(2) Vital (%) for small and large VFN-M2 PDXs.

In contrast, the higher sO(2) Vital values ranging from 57.1 +/- 4.8 to 40.8 +/- 5.7 sO(2) Vital (%) (small to large) of VFN-M5 R1 tumors corresponds with the higher aggressiveness of that PDX model. The different tumor percentage vascularization (assessed as micro-vessel areas) of VFN-M1, VFN-M2 and VFN-M5 R1 obtained by color Doppler (2.8 +/- 0.1%, 3.8 +/- 0.8% and 10.3 +/- 2.7%) in large-stage tumors clearly corresponds with their diverse growth and aggressiveness.

The data obtained by color Doppler were validated by histology. In conclusion, USPAI rapidly and accurately provided relevant and reproducible information on tissue oxygenation in PDX tumors in real time without the need for a contrast agent. (C) 2020 The Author (s).

Published by Elsevier Inc. on behalf of World Federation for Ultrasound in Medicine & Biology.